Neurodegenerative conditions, also known as degenerative neurological disorders, refer to a diffuse set of disorders that cause a progressive decline in cognitive and motor functions. The most common of these include Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Huntington’s disease, and multiple sclerosis, but there are numerous other less common forms of neurodegenerative disease. Neurodegenerative conditions are typically caused by a gradual and accumulative damage to the brain cells. Over time, these cells can become too damaged to perform their normal functions and eventually die off. This can result in a loss of crucial motor and cognitive functioning, causing symptoms such as impaired speech, difficulty walking, impaired memory, and personality changes. Underlying biological mechanisms of neurodegenerative conditions are complex and largely unknown. They involve a combination of genetic, environmental, and lifestyle factors that can cause the disease to progress. In many cases, the cause of neurodegenerative diseases is still a mystery. Treatment for these conditions is based on managing and alleviating symptoms rather than curing the disease. The treatment typically involves a combination of medications, physical and occupational therapy, and lifestyle modification.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom